# Seer, Inc (SEER) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/SEER
## Company Profile
- Ticker: SEER
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 2.19 USD
- Market cap: 102815500.37 USD
- Last updated: 2026-08-05
## Business Overview
### Deep Proteomics Company
Seer develops tools for large-scale, unbiased analysis of the proteome across research, translational medicine, and drug development.
### Proteograph Product Suite
The Proteograph platform combines engineered nanoparticles, automated sample processing, consumables, and analytical software to capture proteins across a wide dynamic range.
### Platform Adoption Model
Seer sells instruments and consumables while supporting service providers and research collaborators. Independent publications and customer-generated datasets provide external validation of the technology.
## Why The Stock Is Moving

As of Aug 5, 2026, SEER closed down 0.90% at $2.19. No new same-company headline was identified in the current news window.

## Future Catalysts

- For Seer, Inc, the near-term story still runs through its latest development priorities. Recent commentary puts the focus on the next company-specific pipeline update. That leaves the stock tied to whether the next milestone lands on schedule.

## Recent News
- 2026-08-03 20:15 EST — [Seer to Participate in the Canaccord Genuity 46th Annual Growth Conference](https://biopharmsignal.com/news/SEER/seer-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference-1f16ca9b) — Source: Seer, Inc
- 2026-08-03 20:05 EST — [Seer to Report Second Quarter 2026 Financial Results on August 11, 2026](https://biopharmsignal.com/news/SEER/seer-to-report-second-quarter-2026-financial-results-on-august-11-2026-2c903d64) — Source: Seer, Inc
- 2026-07-30 21:30 EST — [Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.](https://biopharmsignal.com/news/SEER/seer-confirms-receipt-of-further-revised-unsolicited-acquisition-proposals-from--cb8f763a) — Source: Seer, Inc
- 2026-07-28 21:40 EST — [Seer Stockholders Vote to Re-Elect All Seven of Seer’s Director Nominees at 2026 Annual Meeting](https://biopharmsignal.com/news/SEER/seer-stockholders-vote-to-re-elect-all-seven-of-seer-s-director-nominees-at-2026-57216236) — Source: Seer, Inc
- 2026-07-20 11:00 EST — [Seer Urges Stockholders to Vote “FOR” Seer’s Highly Qualified Director Nominees on the BLUE Proxy Card TODAY](https://biopharmsignal.com/news/SEER/seer-urges-stockholders-to-vote-for-seer-s-highly-qualified-director-nominees-on-6787833a) — Source: Seer, Inc